welbournes

/welbournes

About welbournes

This author has not yet filled in any details.
So far welbournes has created 432 blog entries.

Medicine Supply Notification: Camellia sinensis extract (Catephen® ) 10% ointment Fluorouracil (Efudix® ) 5% cream Imiquimod (Aldara® 5% and Zyclara® 3.75%) cream 250mg sachets

Update (03/02/2025): Updates to communication (MSN/2024/109) issued 26 November 2024 in bold Department of Health and Social Care (DHSC) has issued a medicine supply notification for Camellia sinensis extract (Catephen®) 10% ointment Fluorouracil (Efudix®) 5% cream Imiquimod (Aldara® 5% and Zyclara® 3.75%) cream 250mg sachets MSN/2024/109U Tier 2 medium impact Date of issue: 26th November [...]

The post Medicine Supply Notification: Camellia sinensis extract (Catephen® ) 10% ointment Fluorouracil (Efudix® ) 5% cream Imiquimod (Aldara® 5% and Zyclara® 3.75%) cream 250mg sachets appeared first on Community Pharmacy England.

By |November 26th, 2024|Lexpos News|Comments Off on Medicine Supply Notification: Camellia sinensis extract (Catephen® ) 10% ointment Fluorouracil (Efudix® ) 5% cream Imiquimod (Aldara® 5% and Zyclara® 3.75%) cream 250mg sachets

Folic acid supplementation – advice to health professionals

UK Chief Medical Officers: Folic Acid Supplementation – Continued advice for those who are planning a pregnancy or newly pregnant Advice to health professionals from UK Chief Medical Officers, UK Chief Nursing Officers and UK Chief Midwifery Officers. Please see the letter from the UK Chief Medical Officers, UK Chief Nursing Officers and UK Chief [...]

The post Folic acid supplementation – advice to health professionals appeared first on Community Pharmacy England.

By |November 25th, 2024|Lexpos News|Comments Off on Folic acid supplementation – advice to health professionals

MHRA Class 3 Medicines Recall: Baclofen 10mg/5ml Oral Solution (Syri Limited, T/A SyriMed)

MHRA Class 3 Medicines Recall: Baclofen 10mg/5ml Oral Solution (Syri Limited, T/A SyriMed) Drug alert number: EL(24)A/56 Date issued: 25 November 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a Class 3 medicines defect information notice for: Baclofen 10mg/5ml Oral Solution (Syri Limited, T/A SyriMed) Company name: Syri Limited, T/A SyriMed Product [...]

The post MHRA Class 3 Medicines Recall: Baclofen 10mg/5ml Oral Solution (Syri Limited, T/A SyriMed) appeared first on Community Pharmacy England.

By |November 25th, 2024|Lexpos News|Comments Off on MHRA Class 3 Medicines Recall: Baclofen 10mg/5ml Oral Solution (Syri Limited, T/A SyriMed)

November 2024 Price Concessions 2nd Update

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (20/11/2024) announced the following list of price concessions for November 2024: Drug Pack size Price concession Benzoyl peroxide 5% / Clindamycin 1% gel 60 £22.06 Brimonidine 0.2% eye [...]

The post November 2024 Price Concessions 2nd Update appeared first on Community Pharmacy England.

By |November 20th, 2024|Lexpos News|Comments Off on November 2024 Price Concessions 2nd Update

Medicine Supply Notification: Levobunolol (Betagan®) 0.5% eye drops 0.4ml unit dose preservative free

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Levobunolol (Betagan®) 0.5% eye drops 0.4ml unit dose preservative free. MSN/2024/108 Tier 2 – medium impact Date of issue: 20th November 2024 Levobunolol (Betagan®) 0.5% eye drops 0.4ml unit dose preservative free are being discontinued from late December 2024 Alternative preservative [...]

The post Medicine Supply Notification: Levobunolol (Betagan®) 0.5% eye drops 0.4ml unit dose preservative free appeared first on Community Pharmacy England.

By |November 20th, 2024|Lexpos News|Comments Off on Medicine Supply Notification: Levobunolol (Betagan®) 0.5% eye drops 0.4ml unit dose preservative free